Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 194

1.

A new policy regarding ovarian resection in young women treated for peritoneal carcinomatosis.

Elias D, Duchalais E, Dartigues P, Duvillard P, Poirot C, Goéré D.

Ann Surg Oncol. 2013 Jun;20(6):1837-42. doi: 10.1245/s10434-013-2879-8. Epub 2013 Feb 1.

PMID:
23370670
2.

Comprehensive study of ovarian metastases in young women with peritoneal pseudomyxoma: is a preservation of fertility possible?

Elias D, Duchalais E, David A, Dartigues P, Duvillard P, Poirot C, Goéré D.

Eur J Surg Oncol. 2013 Jul;39(7):748-53. doi: 10.1016/j.ejso.2013.03.005. Epub 2013 Mar 21.

PMID:
23523317
3.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: the Danish experience.

Iversen LH, Rasmussen PC, Hagemann-Madsen R, Laurberg S.

Colorectal Dis. 2013 Jul;15(7):e365-72. doi: 10.1111/codi.12185.

PMID:
23458368
4.

[Cytoreductive surgery and intraperitoneal hyperthermic-antiblastic therapy (HAPP) in peritoneal carcinomatosis].

Vaira M, Scuderi S, Costamagna D, Barone R, Aghemo B, Mioli PR, De Simone M.

Minerva Chir. 2002 Oct;57(5):597-605. Review. Italian.

PMID:
12370661
5.

Quality of life in patients after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is it worth the risk?

Tsilimparis N, Bockelmann C, Raue W, Menenakos C, Perez S, Rau B, Hartmann J.

Ann Surg Oncol. 2013 Jan;20(1):226-32. doi: 10.1245/s10434-012-2579-9. Epub 2012 Aug 7.

PMID:
22868919
6.

Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results.

Golse N, Bakrin N, Passot G, Mohamed F, Vaudoyer D, Gilly FN, Glehen O, Cotte E.

J Surg Oncol. 2012 Aug 1;106(2):197-203. doi: 10.1002/jso.23062. Epub 2012 Feb 13.

PMID:
22331814
7.

[Clinical practice guideline on peritoneal carcinomatosis treatment using surgical cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy].

Kavanagh M, Ouellet JF; Comité de l'Evolution des Pratiques en Oncologie.

Bull Cancer. 2006 Sep;93(9):867-74. Review. French.

8.

Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.

Yang XJ, Li Y, al-shammaa Hassan AH, Yang GL, Liu SY, Lu YL, Zhang JW, Yonemura Y.

Ann Surg Oncol. 2009 Feb;16(2):345-51. doi: 10.1245/s10434-008-0226-2. Epub 2008 Nov 19.

PMID:
19018599
9.

Risk of Ovarian Involvement in Advanced Colorectal or Appendiceal Tumors Involving the Peritoneum.

Mehta AM, Bignell MB, Alves S, Dayal SP, Mohamed F, Cecil TD, Moran BJ.

Dis Colon Rectum. 2017 Jul;60(7):691-696. doi: 10.1097/DCR.0000000000000791.

PMID:
28594718
10.

Management of peritoneal surface malignancy: a review of the recent literature.

Halkia E, Gavriel S, Spiliotis J.

J BUON. 2014 Jul-Sep;19(3):618-26. Review.

PMID:
25261643
11.

Peritonectomy and hyperthermic intraperitoneal chemotherapy: cost analysis and sustainability.

Bagnoli PF, Cananzi FC, Brocchi A, Ardito A, Strada D, Cozzaglio L, Mussi C, Brusa S, Carlino C, Borrelli B, Alemanno F, Quagliuolo V.

Eur J Surg Oncol. 2015 Mar;41(3):386-91. doi: 10.1016/j.ejso.2014.12.004. Epub 2014 Dec 19.

PMID:
25554680
12.

Peritoneal metastases from colorectal cancer: patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Riss S, Mohamed F, Dayal S, Cecil T, Stift A, Bachleitner-Hofmann T, Moran B.

Eur J Surg Oncol. 2013 Sep;39(9):931-7. doi: 10.1016/j.ejso.2013.06.001. Epub 2013 Jun 27. Review.

PMID:
23810280
13.

Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in peritoneal carcinomatosis.

Nesher E, Greenberg R, Avital S, Skornick Y, Schneebaum S.

Isr Med Assoc J. 2007 Nov;9(11):787-90.

14.

[Treatment of peritoneal carcinomatosis with surgery and hyperthermic peroperative intraperitoneal chemotherapy (HIPEC): new aspects and validated indications].

Eveno C, Dagois S, Guillot E, Gornet JM, Pocard M.

Bull Cancer. 2008 Jan;95(1):141-5. doi: 10.1684/bdc.2008.0553. Review. French.

15.

[Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].

Minicozzi A, Borzellino G, Momo EN, Segattini C, Pitoni F, Steccanella F, De Manzoni G.

Ann Ital Chir. 2008 Jul-Aug;79(4):231-9. Italian.

PMID:
19093624
16.

Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Experience of ten years.

Vaira M, Cioppa T, D'Amico S, de Marco G, D'Alessandro M, Fiorentini G, De Simone M.

In Vivo. 2010 Jan-Feb;24(1):79-84.

PMID:
20133981
17.

Ovarian metastasis is associated with retroperitoneal lymph node relapses in women treated for colorectal peritoneal carcinomatosis.

Eveno C, Goéré D, Dartigues P, Honoré C, Dumont F, Tzanis D, Benhaim L, Malka D, Elias D.

Ann Surg Oncol. 2013 Feb;20(2):491-6. doi: 10.1245/s10434-012-2623-9. Epub 2012 Sep 7.

PMID:
22956066
18.

Treatment of peritoneal carcinomatosis from colorectal cancer by cytoreductive surgery and hyperthermic perioperative intraperitoneal chemotherapy.

Kecmanovic DM, Pavlov MJ, Ceranic MS, Sepetkovski AV, Kovacevic PA, Stamenkovic AB.

Eur J Surg Oncol. 2005 Mar;31(2):147-52.

PMID:
15698730
19.

Secondary cytoreductive surgery and peri-operative intraperitoneal chemotherapy for peritoneal recurrence of colorectal and appendiceal peritoneal carcinomatosis following prior primary cytoreduction.

Klaver YL, Chua TC, Verwaal VJ, de Hingh IH, Morris DL.

J Surg Oncol. 2013 May;107(6):585-90. doi: 10.1002/jso.23303. Epub 2012 Dec 27.

PMID:
23280508
20.

[Updated treatment of peritoneal carcinomas: a review].

Deraco M, Laterza B, Kusamura S, Baratti D.

Minerva Chir. 2007 Dec;62(6):459-76. Review. Italian.

PMID:
18091656

Supplemental Content

Support Center